Explore the categories so you can find more about your search.
Categorie > Multiple Sclerosis
Global Image Of Multiple Sclerosis Expresses Through Photographic Exhibit
Categorie : Multiple SclerosisA new photographic exhibit, called "The Image of MS" has been unveiled at the Ara Pacis Museum in Rome to dispel myths about multiple sclerosis (MS), challenge public perceptions about the disease, and encourage those with symptoms to seek treatment as early as possible. [click link for full article ...
read more 
Mon Mar 2007
Stroke Damage Keeps Brain Regions From 'Talking' To Each Other
Categorie : Multiple SclerosisNeuroscientists at Washington University School of Medicine in St. Louis have linked a common post-stroke disability to impaired communication between brain regions.In Neuron, researchers report a tight correlation between the degree to which communication was blocked and the severity of patients' s ...
read more Sat Mar 2007
Primary Endpoint Met In Phase 2 Trial Of Daclizumab In Patients With Relapsing Multiple Sclerosis
Categorie : Multiple SclerosisBiogen Idec, Inc. (Nasdaq: BIIB) and PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) announced today that the ongoing CHOICE trial, a Phase 2, randomized, double-blind, placebo-controlled trial of daclizumab, met its primary endpoint in relapsing multiple sclerosis (MS) patients being treated with interfe ...
read more Tue Mar 2007
Advocacy, Educational Events, And Community Outreach Highlight The Activities Planned By The Multiple Sclerosis Association Of America
Categorie : Multiple SclerosisJoin the Multiple Sclerosis Association of America (MSAA) in raising awareness for multiple sclerosis (MS) during the month of March. MSAA will be hosting various events designed to expand knowledge, understanding, and support of individuals whose lives are affected by multiple sclerosis. [click li ...
read more Wed Feb 2007
Cannabis Based Medicine (Sativex®) Relieves Spasms And Stiffness In People With Multiple Sclerosis
Categorie : Multiple SclerosisToday, a leading neurology journal - European Journal of Neurology (EJN) reports a study1 which shows that Sativex, a cannabis based medicine, significantly reduces intractable spasms and stiffness (spasticity) in people with Multiple Sclerosis (MS). Spasticity is one of the most common symptoms of ...
read more Wed Feb 2007
Neurological Disorders Affect Millions Globally, According To WHO
Categorie : Multiple SclerosisA new report from the World Health Organization (WHO) shows that neurological disorders, ranging from epilepsy to Alzheimer disease, from stroke to headache, affect up to one billion people worldwide. Neurological disorders also include brain injuries, neuroinfections, multiple sclerosis and Parkins ...
read more Wed Feb 2007
New Fellowship To Study Multiple Sclerosis, University Of Queensland, Australia
Categorie : Multiple SclerosisThe University of Queensland today announced the launch of a new fund to improve understanding of, and work towards a cure for, multiple sclerosis. UQ Vice-Chancellor Professor John Hay, AC, announced that the University would contribute $25,000 towards a fund to establish a Multiple Sclerosis Senio ...
read more Mon Feb 2007
'Benign' MS May Not Be So Benign
Categorie : Multiple SclerosisPeople who have multiple sclerosis (MS) for 10 years and have few of the disabling symptoms of the disease are often told they have "benign MS" and that their symptoms will likely not ever occur to the same extent as other people with MS. A new study, published in the February 13, 2007, issue of Neu ...
read more Mon Feb 2007
Extent Of Brain Involvement At Diagnosis May Predict Rate Of Later Brain Atrophy In Patients With MS
Categorie : Multiple SclerosisIn patients with recently diagnosed multiple sclerosis, the extent of accumulated brain tissue loss and overall lesion load as determined by magnetic resonance imaging (MRI) may predict the rate of cerebral atrophy over the following two years, according to a report in the Archives of Neurology, one ...
read more Fri Feb 2007
Stress Response Prevents Neurodegeneration
Categorie : Multiple SclerosisMultiple sclerosis (MS) is a debilitating immune-mediated disease of the brain and spinal cord (the central nervous system [CNS]). It is characterized by infiltration of the CNS by inflammatory cells and destruction of cells that reside in the CNS, known as oligodendrocytes (ODCs). The soluble facto ...
read more Tue Feb 2007
Updated Rates Of Common U.S. Neurological Disorders
Categorie : Multiple SclerosisIn an up-to-date review of most of the common neurological disorders in the United States published in the January 30, 2007, issue of Neurology®, the scientific journal of the American Academy of Neurology, researchers reviewed studies from nearly 500 articles published between 1990 and 2005 to dete ...
read more Fri Feb 2007
Family Members With MS Likely To Share Onset Age, But Not Disease Severity
Categorie : Multiple SclerosisWhen more than one member of a family is affected by multiple sclerosis (MS), their ages at disease onset are likely to be similar, but disease severity may not be. These new findings have important implications for counseling patients, according to a study published in the January 30, 2007, issue o ...
read more Fri Feb 2007
Carbon Monoxide Protects Mice From Multiple Sclerosis
Categorie : Multiple SclerosisMultiple sclerosis (MS) is a chronic inflammatory disorder that causes degeneration of the nerves in the brain and spinal cord, leading to various symptoms including muscle weakness and pain. Most individuals with MS go through cycles of disease and remission, leading to the suggestion that there ar ...
read more Tue Jan 2007
BioMS Medical Completes Patient Recruitment In MAESTRO-01 Pivotal Phase II/III Multiple Sclerosis Trial Of MBP8298
Categorie : Multiple SclerosisBioMS Medical Corp (TSX: MS), a leading developer of products for the treatment of multiple sclerosis (MS), today announced that it has completed patient recruitment in its pivotal phase II/III clinical trial of MBP8298 for the treatment of secondary progressive MS. The trial, named MAESTRO-01, will ...
read more Tue Jan 2007
BioMS Medical Cleared By FDA To Initiate Pivotal Phase III Multiple Sclerosis Trial
Categorie : Multiple SclerosisBioMS Medical Corp (TSX: MS), a leading developer of products for the treatment of multiple sclerosis (MS), announced today that it has received clearance from the United States Food and Drug Administration (FDA) of its Investigational New Drug Application (IND) for the initiation of a pivotal phase ...
read more Sat Jan 2007
Biogen Idec Initiates Phase III Clinical Program Of Oral Compound Bg-12 For Multiple Sclerosis
Categorie : Multiple SclerosisBiogen Idec (NASDAQ: BIIB) announced today that it has initiated the Phase III clinical program of BG-12, an oral fumarate in development for relapsing-remitting multiple sclerosis (MS).The DEFINE (determination of the efficacy and safety of oral fumarate in relapsing-remitting MS) and CONFIRM (comp ...
read more Mon Jan 2007
$5 Million Gift Establishes Judith Jaffe Multiple Sclerosis Unit At Weill Cornell Medical College
Categorie : Multiple SclerosisThe Feil Family Foundation, with matching funds from the Dean's Challenge, has pledged $5.33 million to establish the new Judith Jaffe Multiple Sclerosis Unit at Weill Cornell Medical College in New York City. The Unit is named for Gertrude and Louis Feil's daughter Judith Jaffe.  The gift will a ...
read more Wed Jan 2007
Code Of A Good Practice On The Rights And Quality Of Life Of People Affected By Multiple Sclerosis - EMSP
Categorie : Multiple SclerosisIn December 2003 the European Parliament approved a report based upon a petition submitted by a British person with Multiple Sclerosis, Louise McVay. This report was actively supported by the European Multiple Sclerosis Platform and all EU Multiple Sclerosis Societies. Health Departments in most mem ...
read more Tue Jan 2007
EU Multiple Sclerosis Conference In Brussels, (29 & 30 May 2007)
Categorie : Multiple SclerosisMajor subjects will be:-- Existing data of MS in Europe-- Data collection and methodology across the EU-- Best Practice and the Code of Good Practice-- MS and the futureThis unprecedented conference is part of the MS-Information Dividend project of the European MS Platform, which will start in 2007 ...
read more Tue Jan 2007
The Risk Of Multiple Sclerosis May Be Decreased By High Levels Of Vitamin D In The Body
Categorie : Multiple SclerosisThe possibility that vitamin D could help protect people from developing multiple sclerosis (MS) has been posited by researchers in recent decades, but evidence to support that link has been scant. In the first large-scale, prospective study to investigate the relationship between vitamin D levels a ...
read more Sun Dec 2006
Custom Search
